Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Filed with BSE · · 3 pages · English
Lord's Mark Industries Limited on 6ix
Earlier from Lord's Mark Industries
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Closure of Trading Window
- Intimation Titled 'From An Indian Innovation To A Global Renal-Care Opportunity: Lord'S Mark Industries Takes Its AI-Powered Dialysis Ecosystem Closer To International Markets'
- Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.
- Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'
Later from Lord's Mark Industries
- Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.
- Intimation Titled -Lord'S Mark Industries Limited Receives MHRA Registration For IVD Portfolio; UK Commercial Sales To Begin December 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Acquisition
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
Follow Lord's Mark Industries into a list and get an email when it puts out news.
Follow Lord's Mark Industries